Preimplantation genetic testing for aneuploidy (PGT-A) is a powerful technology that can help families understand the risk of passing on certain inherited genetic conditions. It is a cutting-edge procedure that can be used during an IVF cycle to determine the chromosomal health of embryos prior to implantation, increasing the chances of successful pregnancy and delivery. This procedure has become increasingly popular as it offers families more options and control when planning their family.
In the case of PGT-A testing, it’s important to strike a balance between perplexity and burstiness. While we want to present the information in a clear and concise manner, we also need to provide enough complexity and variation to fully convey the intricacies of the topic.
Benefits of PGT-A Testing
PGT-A testing can have a significant impact on the success rate of in vitro fertilization (IVF). By screening embryos for chromosomal abnormalities prior to implantation, PGT-A can increase the chances of having a successful pregnancy. Here are some of the benefits of PGT-A testing:
- Improved Chances Of Successful Pregnancy: One of the biggest benefits of PGT-A is that it improves the chances of achieving a successful pregnancy. Embryos with chromosomal abnormalities may not be able to survive to term and may lead to miscarriage or unsuccessful implantation. By identifying these embryos prior to implantation, this procedure can help ensure that only healthy embryos are implanted, increasing the odds for a successful pregnancy.
- Reduced Risk Of Genetic Diseases: Another major benefit of PGT-A is its ability to reduce the risk of passing on genetic diseases from parent to child. Preimplantation genetic diagnosis (PGD) allows couples who carry known genetic diseases or mutations in their family lineages, such as cystic fibrosis or Huntington’s disease, screen their embryos for those specific conditions before implantation. This ensures that only embryos free of the disease would be implanted, significantly increasing the chances of a healthy baby being born.
Who Should Undergo PGT-A Testing
PGT-A testing is recommended for couples or individuals with a known genetic disorder, as it can significantly increase the chances of a healthy baby being born. In addition, women over 35 may consider undergoing PGT-A testing due to their increased risk of carrying abnormal embryos. As women age, their eggs are more likely to produce chromosomally abnormal embryos, meaning there’s an increased risk for miscarriage and other pregnancy complications such as Down Syndrome and other chromosomal disorders. By screening IVF created embryos through PGT-A testing prior to implantation, this risk can be minimized or eliminated altogether depending on individual circumstances.
PGT-A testing is expensive, with the cost ranging from $2,000 to $4,000 per cycle, depending on the clinic. This cost does not include additional fees such as storage.